<DOC>
	<DOCNO>NCT01534234</DOCNO>
	<brief_summary>The objective study assess safety effectiveness automatic atrioventricular ( AV ) delay interventricular ( VV ) delay optimization algorithm use PARADYM RF SONR Cardiac Resynchronization Therapy Defibrillation ( CRT-D ) device ( Model 9770 ) combination SonRtip Lead , include SonR sensor tip atrial pace lead , compatible SmartView programming software . This study evaluate effectiveness automatic optimization algorithm increase rate patient respond therapy compare echocardiographic optimization method . This study also evaluate safety effectiveness SonRtip atrial pace lead .</brief_summary>
	<brief_title>Clinical Trial SonRtip Lead Automatic AV-VV Optimization Algorithm PARADYM RF SonR CRT-D</brief_title>
	<detailed_description>Since introduction cardiac resynchronization therapy ( CRT ) large scale , observe approximately 30 % recipient patient non-responsive therapy . This non-responsiveness decreased optimize device programming , particularly stimulation rate , pace sense atrioventricular ( AV ) delay , interventricular ( VV ) delay . All CRT patient need 100 % rate ventricular capture , beyond achievement therapy effectiveness require identification optimal pacing configuration , varies among patient . The optimization CRT system , usually base ultrasound image time-consuming number patient need multiple optimization procedure due ventricular remodel grow rapidly . The mechanical effect coordinate contraction result shorten isovolumetric contraction phase pre-ejection time , increase LV dP/dt ( change leave ventricular pressure time . The concept measure contractility implantable accelerometer first clinically validate multicenter study rate responsive pacing system ( BEST - Living SORIN Biomedica ) 1996 . This study positively demonstrate measurement Peak Endocardial Acceleration signal ( call PEA SonR ) feasible reliable long-term , purpose rate response hemodynamic monitor cardiac function . More recent clinical study demonstrate optimal VV AV Delays determine use algorithm base SonR signal analysis ( SonR method ) correlate high hemodynamic improvement lead significant clinical benefit patient , thus reduce rate non-responsiveness CRT therapy . Therefore , automatic AV VV delay optimization patient CRT device could benefit patient physician .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>1 . Patient eligible class I IIa indication implantation CRTD device accord current available guideline ; 2 . Modere , Severe HF ( NYHA Class III ambulatory IV ) 3 . LVEF ≤ 35 % 4 . LBBB : QRS ≥ 120 m ; nonLBBB : QRS ≥ 150 m 5 . On stable , optimal drug regimen 6 . Patient sinus rhythm time enrollment ; 7 . Signed date informed consent 1 . Ventricular tachyarrhythmia transient reversible cause acute myocardial infarction , digitalis intoxication , drown , electrocution , electrolyte imbalance , hypoxia sepsis , uncorrected time enrolment ; 2 . Incessant ventricular tachyarrhythmia ; 3 . Unstable angina , acute MI , CABG , PTCA within past 4 week ; 4 . Correctable valvular disease primary cause heart failure ; 5 . Recent CVA TIA ( within previous 3 month ) ; 6 . Persistent permanent atrial arrhythmia ( cardioversion atrial fibrillation ) within past month ; 7 . Post heart transplant ( patient wait heart transplant allow study ) ; 8 . Renal failure ( GFR &lt; 15 ml/min/1.73m2 ) dialysis 9 . Previous implant CRT/CRTD device ; 10 . Concurrent implant another pacemaker ICD ( previously implant pacemaker ICD device RA lead remove prior implant Paradym RF SONR CRTD ) ; 11 . Already include another clinical study could confound result study ; 12 . Life expectancy less 1 year ; 13 . Inability understand purpose study understand complete QOL questionnaire ; 14 . Unavailability schedule followup refusal cooperate ; 15 . Sensitivity 1 mg dexamethasone sodium phosphate ( DSP ) 16 . Age le 18 year ; 17 . Pregnancy 18 . Drug addiction abuse 19 . Under guardianship</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>CRT-D device</keyword>
	<keyword>Severe HF ( NYHA Class III ambulatory IV )</keyword>
	<keyword>stable , optimal drug regimen</keyword>
	<keyword>sinus rhythm</keyword>
</DOC>